Expert Review of Pharmacoeconomics & Outcomes Research

• Economics of Drug-Drug Interactions in Chronic Pain Patients You may be surprised that all patients regardless of age are at risk for drug interactions with opioids.
  Expert Review of Pharmacoeconomics & Outcomes Research, February 14, 2014
• ADHD: An Update on Medication Adherence and Persistence What social factors predict adherence to ADHD medications?
  Expert Review of Pharmacoeconomics & Outcomes Research, January 15, 2014
• The Economic Value of Reducing the Stigma of HIV/AIDS Are HIV stigma interventions socially worthwhile?
  Expert Review of Pharmacoeconomics & Outcomes Research, December 16, 2013
• Outpatient Palliative Care Effectiveness: All Can Gain Can an outpatient palliative care team decrease the burden on caregivers?
  Expert Review of Pharmacoeconomics & Outcomes Research, November 15, 2013
• Burdens of SREs Associated With Bone Metastases Do patients with skeletal-related events have decreased survival?
  Expert Review of Pharmacoeconomics & Outcomes Research, October 16, 2013
• Reforms and Initiatives to Encourage Prescribing of Generics Can increased generic prescribing reduce pharmaceutical expenditures without compromising patient care?
  Expert Review of Pharmacoeconomics & Outcomes Research, September 16, 2013
• Cost Analysis of Albumin-Bound Paclitaxel vs Paclitaxel Is standard paclitaxel more cost-effective than nanoparticle albumin-bound paclitaxel?
  Expert Review of Pharmacoeconomics & Outcomes Research, August 16, 2013
• Vaccination Against Herpes Zoster and Postherpetic Neuralgia Is herpes zoster vaccination worth the cost?
  Expert Review of Pharmacoeconomics & Outcomes Research, July 18, 2013
• Cost-effectiveness of Prevention for Depressive Disorders Does preventive psychotherapy decrease health care costs?
  Expert Review of Pharmacoeconomics & Outcomes Research, June 18, 2013
• Antifungal Pharmacoeconomics in Hematologic Cancer and HSCT Is antifungal therapy cost-effective for empirical treatment of invasive fungal infections?
  Expert Review of Pharmacoeconomics & Outcomes Research, May 17, 2013
• Burden of Hypoglycemia in Insulin-Treated Patients With DM What are the 'hidden' costs of hypoglycemia?
  Expert Review of Pharmacoeconomics & Outcomes Research, April 18, 2013
• Demand-side Policies to Encourage Generic Medicine Use What are physician perceptions of generic drug efficacy and quality?
  Expert Review of Pharmacoeconomics & Outcomes Research, March 18, 2013
• Cost Offsets and Cost-Effectiveness With Pegylated Drugs Pegylated drugs have many benefits?Is cost-savings one?
  Expert Review of Pharmacoeconomics & Outcomes Research, March 04, 2013
• Delivering Cost–Effective Care for COPD in the USA What are the barriers to cost-effective care in COPD management?
  Expert Review of Pharmacoeconomics & Outcomes Research, February 17, 2013
• Pharmacoeconomics of Managing Acute Agitation in the ED How much does managing agitation in the ED cost?
  Expert Review of Pharmacoeconomics & Outcomes Research, January 17, 2013
• Demand for Male Contraception Why aren't pharmaceutical companies developing hormonal contraceptives for men?
  Expert Review of Pharmacoeconomics & Outcomes Research, December 17, 2012
• Lifestyle Factors on Prognosis Among Breast Cancer Survivors Can healthy diet and exercise help breast cancer survivors live longer?
  Expert Review of Pharmacoeconomics & Outcomes Research, October 31, 2012
• Autism Spectrum Disorders: Outcomes Applications Which outcomes instruments can measure clinical services in autism spectrum disorders?
  Expert Review of Pharmacoeconomics & Outcomes Research, August 01, 2012
• Switching Among Biologic Therapies in Rheumatoid Arthritis Can biologics be interchanged safely?
  Expert Review of Pharmacoeconomics & Outcomes Research, August 31, 2012
• Cost-Effectiveness of Preventing Weight Gain and Obesity Is physical activity for weight control cost effective?
  Expert Review of Pharmacoeconomics & Outcomes Research, June 01, 2012